Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Dr Harsh Vardhan inaugurates CEPI centralized network lab in Faridabad to assess Covid-19 vaccine candidate immunogenicity

Ruchika Sharma6 Jan 2021 9:45 AM IST

All COVID19 vaccine developers can use CEPI network for free to assess immunogenicity of their vaccine candidate against a common protocol, using...

Serum Institute COVID-19 vaccine priced at Rs 292, Rs 586 for Govt, private market respectively

Ruchika Sharma5 Jan 2021 3:00 PM IST

New Delhi: Coronavirus vaccine developed by AstraZeneca and the University of Oxford will cost USD 3-4 per shot (Rs 219-292) to the government and...

Sun Pharma begins Phase 2 Trial of SCD-044 for Plaque Psoriasis

Ruchika Sharma5 Jan 2021 12:41 PM IST

Mumbai: Sun Pharmaceutical Industries Limited today announced that the company has initiated Phase 2 clinical trial for SCD-044 (a novel, orally...

DCGI rebuffs impotency rumours as complete nonsense, says COVID-19 vaccines 110 percent safe

Ruchika Sharma4 Jan 2021 1:03 PM IST

New Delhi: As India gears up for the world's largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelled rumours...

Govt to set up 3 bulk drug parks to make APIs for medicine

Ruchika Sharma4 Jan 2021 12:35 PM IST

"It is high time we produce also the chemicals and other raw materials used in making live-saving drugs rather than depend on China," said Gowda in a...

Zydus Cadila secures DCGI nod to start Phase III Clinical Trial of ZyCoV-D to prevent COVID

Ruchika Sharma4 Jan 2021 12:28 PM IST

ZyCoV-D was found to be safe, well tolerated and immunogenic in the Phase I/II clinical trials.

Alniche Lifesciences forays into pharma manufacturing by setting up EffiKasia Lifesciences

Ruchika Sharma3 Jan 2021 10:30 AM IST

New Delhi: In this new year, Alniche Lifesciences has achieved a new milestone by venturing into manufacturing in its state-of-the-art facility under...

Pfizer, BioNTech to offer COVID-19 vaccine to volunteers who received placebo by March 1

Ruchika Sharma3 Jan 2021 10:15 AM IST

New Delhi: Pfizer Inc and its partner BioNTech Se plan to give volunteers who received a placebo in its COVID-19 vaccine trial an option to receive a...

Pfizer, Sanofi, GSK, others to hike prices on more than 300 drugs in 2021

Ruchika Sharma3 Jan 2021 10:00 AM IST

New York: Drugmakers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S. prices on more than 300 drugs in the United States,...

AstraZeneca discontinues Phase 3 trial of prostate cancer drug Truqap

Two million doses of AstraZeneca COVID vaccine set to be supplied every week by mid-January in UK: Report

Ruchika Sharma2 Jan 2021 1:53 PM IST

New Delhi: About two million doses of COVID-19 vaccine developed by Oxford University and AstraZeneca are set to be supplied every week by the middle...

BioNTech founders warn of COVID-19 vaccine supply gaps: Spiegel

Ruchika Sharma2 Jan 2021 1:24 PM IST

Berlin: BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders said, warning there would be gaps...

Moderna, Republic of Korea Govt ink pact for 40 million doses of COVID-19 vaccine

Ruchika Sharma2 Jan 2021 10:00 AM IST

Cambridge: Pharma major, Moderna, Inc., has confirmed that the Company has entered into a supply agreement with the government of the Republic...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok